Recent News

• 03.03.2025 - BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.20.2025 - BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025
• 02.19.2025 - How to prepare early for regulatory submissions from IND to BLA
• 01.22.2025 - Navigating Current Standards and Compliance for Cell and Gene Therapy (CGT) Storage Containers
• 01.13.2025 - BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations

Recent Filings

• 03.03.2025 - EX-99.1 EX-99.1
• 03.03.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.03.2025 - 8-K Current report
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - 8-K Current report
• 01.13.2025 - EX-99.1 EX-99.1